Insider · CIK 0001756228
Lance Alstodt
Files at BRTX (BioRestorative Therapies, Inc.). First filing -, latest -.
Lance Alstodt files SEC Form 4 as CEO, president, director and 10% owner at BRTX (BioRestorative Therapies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lance Alstodt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | BRTX BioRestorative Therapies, Inc. | AGrant or award Common Stock | +15,625 | $1.60 | $25k | 187,497 | Oct 20, 2025 |
| Oct 6, 2025 | BRTX BioRestorative Therapies, Inc. | AGrant or award Warrantderivative | +11,719 | $0.00 | $0 | 11,719 | Oct 20, 2025 |
| Feb 14, 2025 | BRTX BioRestorative Therapies, Inc. | AGrant or award Stock Optionderivative | +791,885 | $0.00 | $0 | 791,885 | Feb 19, 2025 |
Questions about Lance Alstodt
Answered from the filings on this page, as of the latest one.
Is Lance Alstodt buying or selling?
Lance Alstodt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lance Alstodt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lance Alstodt has 0.
Where does Lance Alstodt file Form 4?
Lance Alstodt has filed Form 4 at BRTX (BioRestorative Therapies, Inc.) as President, CEO, COB. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.